Development and Validation of a Quantitative Polymerase Chain Reaction Assay to Evaluate Minimal Residual Disease for T-Cell Acute Lymphoblastic Leukemia and Follicular Lymphoma
- 30 April 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 154 (4) , 1023-1035
- https://doi.org/10.1016/s0002-9440(10)65355-2
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Extensive allelic sequence variation in the J region of the human immunoglobulin heavy chain gene locusEuropean Journal of Immunology, 1995
- Detection of Minimal Residual Disease in Acute Myelogenous LeukemiaJournal of Pediatric Hematology/Oncology, 1995
- Techniques for Detection of Minimal Residual DiseaseLeukemia & Lymphoma, 1995
- Detection of Chromosomal Translocations :in Leukemia-Lymphoma Cells by Polymerase Chain ReactionLeukemia & Lymphoma, 1995
- Clinical Significance of Minimal Residual Disease in Leukemia Detected by Polymerase Chain Reaction: Is Molecular Remission a Milestone for Achieving a Cure?Leukemia & Lymphoma, 1994
- Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaThe Lancet, 1992
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986
- Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18Cell, 1985
- Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1982
- A Reappraisal of the Results of Stopping Therapy in Childhood LeukemiaNew England Journal of Medicine, 1979